Langerhans Cell Histiocytosis clinical trials

Explore recruiting langerhans cell histiocytosis clinical trials.

Recruiting langerhans cell histiocytosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Langerhans Cell Histiocytosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis

Czechia, Netherlands, Italy, Austria, Norway, Spain +6 more

Phase II and Phase III (Integrated) EU CTIS Study details

Optimalization Of The Time And Dosage Of Trametinib In BRAF Negative Juvenile Patients With Refractory Histiocytosis Or After Failure Of Vemurafenib Treatment.

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Determination Of Molecular Status And Benefit Of Use Fludeoxyglucose (18F-FDG) In PET/CT imagining In Juvenile Patients With Histiocytosis

Poland

Therapeutic use (Phase IV) EU CTIS Study details

Optimalization Of The Time And Dosage Of Vemurafenib In BRAF Positive Juvenile Patients With Refractory Histiocytosis

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Langerhans Cell Histiocytosis trials by city

Langerhans Cell Histiocytosis in Toronto Langerhans Cell Histiocytosis in Vancouver Langerhans Cell Histiocytosis in Montreal Langerhans Cell Histiocytosis in Calgary Langerhans Cell Histiocytosis in Edmonton Langerhans Cell Histiocytosis in Ottawa Langerhans Cell Histiocytosis in Winnipeg Langerhans Cell Histiocytosis in Quebec City Langerhans Cell Histiocytosis in Hamilton Langerhans Cell Histiocytosis in Kitchener Langerhans Cell Histiocytosis in London Langerhans Cell Histiocytosis in Halifax Langerhans Cell Histiocytosis in New York Langerhans Cell Histiocytosis in Los Angeles Langerhans Cell Histiocytosis in Chicago Langerhans Cell Histiocytosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease